FLORETTE DORVIL: Open Payments
NPI 1912563057 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 54 payments from 14 companies in 2025. Trend: 2023 $844 · 2024 $988 · 2025 $1,115
Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $272 |
| Exact Sciences Corporation | 6 | $145 |
| Lilly USA, LLC | 5 | $122 |
| GlaxoSmithKline, LLC. | 5 | $117 |
| Novo Nordisk Inc | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| PFIZER INC. | 4 | $75 |
| Lundbeck LLC | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Braeburn Inc. | 1 | $33 |
Products named: MOUNJARO, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, UBRELVY, Kerendia, Ozempic, QULIPTA, REXULTI.
Industry payments across PA — which companies pay providers there.
